Gerald Andriole Jr

Gerald L. Andriole, Jr., MD

  • Chief, Division of Urologic Surgery
  • Robert K. Royce Distinguished Professor of Urologic Surgery
  • Vice Chair, Department of Surgery

Medical School

Jefferson Medical College, Philadelphia, 1978

Post Doctoral Education

Residency: Surgery, Strong Memorial Hospital, University of Rochester, Rochester, New York, 1980

Residency: Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 1983

Fellowship: National Cancer Institute, 1985

Board Certifications


Honors and Awards

1989-present, Listed in Best Doctors in America, (Best Doctors, Inc.)

1999-present, Listed in America's Top Doctors, 7th Edition, Castle Connolly Medical Ltd.

2002, Outstanding Achievement Award, Urologic Oncology Branch, National Cancer Institute

1995, CIAO Award for Medicine

1994, American Urological Association /European Association of Urology International Academic Exchange Program

1988, American Urological Association Audiovisual Award, First Prize, 83rd Annual Meeting

1978, Theodore H. Fetter Award (Urologic Surgery), Jefferson Medical College

Clinical Interests

Dr. Andriole specializes in urologic oncology, prostate cancer and urologic surgery. His areas of clinical interest include prostate cancer, benign prostate hyperplasia, prostatectomy, prostate specific antigen (PSA).

Research Interests

National Cancer Institute
Prostate, Lung, Colorectal and Ovarian Cancer Screening Study

National Institutes of Health/National Cancer Institute
Survivor HRQOL and Spouse Satisfaction after Prostate Therapy

National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) study

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St. Louis Children's Hospital
St. Louis VA Medical Center
Progress West HealthCare Center

Patients Seen At

Center for Advanced Medicine
Urologic Surgery Center
4921 Parkview Place, Suite C, Floor 11
St. Louis, MO 63110
(314) 362-8200
Fax: (314) 361-2203

Barnes-Jewish West County Hospital
Professional Office Building #1
1040 North Mason Road, Suite 122
St. Louis, MO 63141
(314) 996-8060

Center for Advanced Medicine - South County
5201 Midamerica Plaza
St. Louis, MO 63129

Selected Publications

Strope SA, Andriole GL. Improving prostate-specific antigen screening. JCO. 2010;28(15):2491-2492.

Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, Ragard LR, Lynch DA, Andriole GL, Buys SS, Fouad M, Fuhrman C, Isaacs C, Yokochi L, Riley TL, Pinsky PF, Gohagan JK, Berg CD. Lung cancer screening in the Randomized Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst. 2010;102(10):722-731.

Wolin KY, Luly J, Sutcliffe S, Andriole GL, Kibel AS. Risk of urinary incontinence following prostatectomy; the role of physical activity and obesity. J Urol. 2010;183(2):629-633.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall, DJ, Somerville MC, Wilson TH, Fowler IL, and Rittmaster RS for the REDUCE Study Group. Effect Of dutasteride on the risk of prostate cancer. NEJM. 2010;362(13):1192-1202.

Prokunina-Olsson L, Fu YP, Wei T, Jacobs KB, Hayes RB, Kraft P, Berndt SI, Wacholder S, Yu K, Hutchinson A, Spencer Feigelson H, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman CA, Henderson BE, Kolonel L, Le Marchand L, Siddiq A, Riboli E, Key TJ, Kaaks R, Isaacs WB, Isaacs SD, Grönberg H, Wiklund F, Xu J, Vatten LJ22, Hveem K, Kumle M, Tucker M, Hoover RN, Fraumeni JF, Hunter DJ, Thomas G, Chatterjee N, Chanock SJ, Yeager M. Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2 Human Molecular Genetics. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1349-1355.

Strope SA, Andriole GL. Update on chemoprevention for prostate cancer. Curr Opin Urol. 2010;20(3):194-197.

Humphrey PA, Andriole GL. Prostate cancer diagnosis. Missouri Medicine. 2010;107(2):107-112.

Shteynshlyuger A, Andriole GL. Prostate cancer: To screen or not to screen. Urologic Clinics of North America. 2010;37(1):1-9.

Crawford ED, Andriole GL, Marberger M, Rittmaster R. Reduction in the risk of prostate cancer: Future directions after the Prostate Cancer Prevention Trial. Urology. 2010;75(3):502-509.

Andriole GL, Rittmaster RS. Dutasteride and Prostate Cancer. Letter-to-the-Editor. Reply by the Authors. New Engl J Med. 2010;363(8):794-795.

Myers RP, Seki N, Gotoh M, Chai TC, Kaplan S, Inoue K, Trachtenberg J, Kikuchi E, Nishiyama H, Chang SS, Lee C, Muto S, Ito K, Andriole GL, Eto M, Sumitomo M, Kamba T, Wood CG, Margulis V, Naito S, Egawa S. Fifth joint meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological Association. Int J Urol. 2010;17(8):743-752.

Strope SA, Andriole GL. Prostate cancer screening: current status and future perspectives. Nat Rev Urol. 2010;7(9):487-493.

Andriole GL. Screening for prostate cancer. BMJ. 2010;341:4538.

Aubin SM, Reid J, Sarno MJ, Blasé A, Ausie J, Rittenhouse H, Rittmaster RS, Andriole GL, Groskopf J. PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: Validation in the placebo arm of the dutasteride REDUCE trial. J Urol. 2010;184:1947-1952.

Pub Med page for Gerald L. Andriole, Jr., M.D.

Dr. Andriole's citations on Google Scholar.

Editorial Positions

Associate Editor, Clinical Genitourinary Cancer, 2010-present
Associate Editor, The 5 Minute Urology Consult, 2008-present
Community Editor, Urologic Surgery, American College of Surgeons Web Portal, 2007-present
Editorial Board, Cornell University Medical College Reports on Men’s Urologic Health, 2006-present
Associate Editor, The Journal of Men’s Health & Gender, 2003-present
Urology Times, Hands-On Editor, 2002-present
Editor-in-Chief, Yearbook of Urology, 1997-present
Editorial Board, Urology Research and Treatment, 1999-present
Editorial Board, Urologia Internationalis, 1997-present
Editorial Consultant, The Paget Society, 1999-present
The Prostate Journal, 1997-present
Editorial Board, Infections in Urology, 1991-present
Editorial Advisory Board, Surgical Rounds, 1990-present

Special Committees

Steering Committee, Prostate Cancer Chemoprevention Trial, 1992-present
Steering Committee, NIH PLCO Cancer Screening Trial, 1992-present
Chairman, Prostate Subcommittee, NCI, PLCO Cancer Screening Trial, 1993-present
Medical Advisory Committee, Prostate Intervention Versus Observation Trial (PIVOT), 1994-present
Commission on Cancer of the American College of Surgeons, 1994-present
Cochrane Collaboration in Prostatic Diseases, 1995-present
AUA/Pfizer Visiting Professor Review Board, 2001-present
Executive Committee, Siteman Cancer Center, 2001-present
Steering Committee, CAMUS Trial (NIH/NIDDK), 2002-present.
Chairman, Steering Committee, REDUCE Trial (Dutasteride Chemoprevention Trial), 2002-present
NCI, Biorepository Scientific Advisory Panel, 2003-present
Society of Urologic Oncology Executive Committee, 2005-present
Panel Member, Blue Ribbon Prostate Institution, 2004-present
Oral Examiner, Exam Committee, American Board of Urology, 2006-present
Society of University Urologists Executive Committee, 2007-present
Steering Committee, NIH, NIDDK MAPP Studies, 2008-present


Andriole GL and Colberg JW. Surgical Management of Penile Cancer. In: NJ Vogelzang (ed.). Comprehensive Textbook of Genitourinary Oncology. Baltimore: Williams and Wilkins; 1996.

Andriole GL, Keetch DW, Dehner LP, Ratliff, TL. Superficial Bladder Cancer. Current Problems in Urology. Lipshultz LI (ed.). St. Louis: Mosby; 1992.